|
Senate Bill 625 |
Senate Author: Janek |
|
Effective: 6-15-07 |
House Sponsor: Davis, John |
Senate Bill 625 amends the Occupations Code to prohibit a pharmacist from interchanging an immunosuppressant drug or formulation of an immunosuppressant drug for the treatment of a patient following a transplant without prior consent from the prescribing practitioner. The bill establishes the process by which a pharmacist can obtain permission for a drug interchange. Senate Bill 625 directs the Texas State Board of Pharmacy and the Texas Medical Board to establish a joint committee to recommend drugs to which the prohibition should apply and includes a list of certain drugs required to be considered by the committee. The bill also sets out procedures relating to a drug manufacturer's request that the committee conduct a hearing and make recommendations regarding a drug specified by the bill for consideration.